Zheqi D. Hu
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Correction to "Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer".
Journal: Journal of medicinal chemistry
Published: March 07, 2026
Plasma extracellular vesicle proteins biomarker for cerebral small vessel disease related cognitive impairment.
Journal: Alzheimer's research & therapy
Published: January 16, 2026
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: January 13, 2026
White Matter Functional Dysregulation in Amyotrophic Lateral Sclerosis: Machine Learning-Based Biomarkers and Transcriptomic Signatures.
Journal: Current neuropharmacology
Published: January 05, 2026
Establishment of the SAFER low-risk, high-quality surgical system for esophageal cancer: an analysis of 131 cases
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: December 24, 2025
A new paradigm for stratified cognitive assessment: fusing serum Raman spectroscopy and ensemble learning.
Journal: Alzheimer's research & therapy
Published: December 22, 2025
A Surface-Engineered Microfluidic Platform with Algorithmic Optimization for Plasma Biomarker Detection in Alzheimer's Disease.
Journal: ACS sensors
Published: November 24, 2025
Neuro-navigated rTMS Targeting Left Angular Gyrus Promotes White-Gray Matter Remodelling to Improve Cognitive Function in Amnestic Mild Cognitive Impairment Patients: Evidence for Early Alzheimer.s Intervention.
Journal: Current neuropharmacology
Published: September 16, 2025
Co-classification network analysis reveals nodal dysfunction and dimension-specific alterations in obstructive sleep apnea-hypopnea syndrome.
Journal: Sleep medicine
Published: August 25, 2025
Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assay.
Journal: Alzheimer's research & therapy
Published: August 20, 2025
Discovery of a novel benzofuran-7-carboxamide-based PARP1/c-Met dual inhibitor for addressing c-Met amplification-mediated PARP1i acquired-resistance.
Journal: European journal of medicinal chemistry
Published: July 17, 2025
Gut Lachnospiraceae improves white matter injury-related cognitive decline by increasing L-arginine.
Gut Lachnospiraceae improves white matter injury-related cognitive decline by increasing L-arginine.
Journal: Cellular & molecular biology letters
Published: July 11, 2025
Last Updated: 09/26/2026